Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Jiangsu Lianhuan Pharmaceutical Co Ltd (600513)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
8.90 +0.05    +0.56%
26/04 - Closed. Currency in CNY ( Disclaimer )
Type:  Equity
Market:  China
ISIN:  CNE000001DP6 
  • Volume: 5,207,877
  • Bid/Ask: 8.90 / 8.91
  • Day's Range: 8.78 - 8.96
Jiangsu Lianhuan Pharm 8.90 +0.05 +0.56%

Jiangsu Lianhuan Pharmaceutical Co Ltd Company Profile

 
Get an in-depth profile of Jiangsu Lianhuan Pharmaceutical Co Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

1276

Equity Type

ORD

Jiangsu Lianhuan Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals, preparations, and API products in China. The company offers clopidogrel bisulfate tablets used to prevent atherothrombotic events; azithromycin tablets for the treatment of mild to moderate infections caused by susceptible strains of designated microorganisms; milrinone injection for short-term intravenous therapy in patients with acute compensated heart failure; and dapoxetine hydrochloride tablets for the treatment of premature ejaculation in men, as well as epulet, ebastine, felodipine, and terfenadine tablets, drotaverine hydrochloride injection, and danazol suppository. It also offers preparation products, which covers urinary system, antihistamines, cardiovascular drugs, steroid hormones, and antibiotics. In addition, the company engages in the wholesale of chemical raw materials and pharmaceuticals, as well as provides technological transfers and technical consultation services. It exports its products to Southeast Asia, North America, South America, Europe, New Zealand, Australia, and other countries. The company was founded in 1999 and is headquartered in Yangzhou, China.

Contact Information

Address No. 9, Jiankang Road Yangzhou Biohealth Industrial Park
Yangzhou, 225127
China
Phone 86 514 8781 3082
Fax 86 514 8781 5079

Top Executives

Name Age Since Title
Heping Pan 59 2012 Vice Chairman, CFO & Accounting Supervisor
Wenge Wu 56 2014 Chairman
Guangji Wang 70 2018 Director
Chunlai Xia 49 2016 Director
Ying Chen 46 - Independent Director
Baochang Yu 39 - Chairman of the Supervisory Board
Bin Zhang 55 - Independent Director
Chunyuan Wang 52 2021 Supervisor
Jing Zhang 35 2021 Employee Supervisor
Zhen Hua Qian 53 2018 Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

600513 Comments

Write your thoughts about Jiangsu Lianhuan Pharmaceutical Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email